New study to uncover withdrawal differences in schizophrenia patients who vape vs. smoke
NCT ID NCT06944847
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how people with schizophrenia experience nicotine withdrawal when they stop vaping or smoking for 24 hours. Researchers will compare withdrawal symptoms, mood, and thinking skills between daily vapers and daily smokers. The goal is to understand nicotine dependence better and create more effective quitting programs for this group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help develop better vaping and smoking cessation programs tailored for people with schizophrenia.
- What could go wrong
- This is an early-stage observational study with only 64 participants, so results may not apply to everyone. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ABSTINENCE FROM CIGARETTES VS E-CIGARETTES (ENDS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University at Buffalo
RECRUITINGBuffalo, New York, 14260, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?